Steven Cohen's position in Repligen is currently worth $231M. That's 0.55% of their equity portfolio (31st largest holding). The investor owns 3.35% of the outstanding Repligen stock. The first Repligen trade was made in Q3 2018. Since then Steven Cohen bought shares sixteen more times and sold shares on thirteen occasions. The investor's estimated purchase price is $271M, resulting in a loss of 15%.